Skip to main content
FoodRecallWatch
Class I, DangerousF-0996-2018

NXTGEN Botanicals, Maeng Da Kratom, Dietary Supplement, 70 Capsules, Made in the U.S.A

Recalled by Avalon Packaging on Mar 9, 2018

Reviewed by FoodRecallWatch Editorial Team · Updated

Recall Summary

Avalon Packaging recalled NXTGEN Botanicals, Maeng Da Kratom, Dietary Supplement, 70 Capsules, Made in the U.S.A in a Class I action — the FDA's most serious tier, reserved for products with a reasonable probability of causing serious health consequences or death on Mar 9, 2018.

The recall was triggered by possible Salmonella contamination: "Avalon Packaging is recalling NXTGEN Kratom because of the potential for Salmonella contamination." Salmonella is one of the most common causes of U.S. foodborne illness, with symptoms that typically appear within six hours to six days of exposure.

The product reached multiple states, recorded by the FDA as "Sold to Label owner in UT." A multi-state footprint means the same lot can surface in households far from the producer. The recalling firm is based in Orem, UT. The recall covers 1108 bottles of product. The FDA has Terminated this recall (first reported Mar 28, 2018), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.

Reason for Recall

Avalon Packaging is recalling NXTGEN Kratom because of the potential for Salmonella contamination.

Product Description

NXTGEN Botanicals, Maeng Da Kratom, Dietary Supplement, 70 Capsules, Made in the U.S.A

Distribution

Sold to Label owner in UT.

What Should You Do?

  • 1.Check your kitchen for this product immediately.
  • 2.Do not consume the recalled product.
  • 3.Return the product to where you bought it for a full refund, or throw it away.
  • 4.If you have experienced any health issues, contact your healthcare provider.

Browse Related Recalls

Food category: Dietary Supplements
States affected: Indiana, Utah

Terms Explained

Source: FDA Recalls, Market Withdrawals and Safety Alerts, 2026.